15
GROWING THE RESPONSIBLE USE OF MEDICINES
What can be done to ensure that children are treated with
the most appropriate products? FIP has been lending its
expertise to the preparation of a joint document with the
WHO that will help guide alternatives to compounding
for children.
FIP s standards for hospital pharmacy (Basel Statements
2008) have been adopted in many places and have had
various indirect influences. However, to keep current
with changes in practice, they are being revised.
The first FIP UNESCO-UNITWIN Centre of Excellence, part of the
FIPEd 5-year Action Plan, is well under way to being launched.
FIP s Statement on Code of Ethics (2004) is being revised
so that it reflects new challenges. It is expected that the
report on ethics and autonomy in pharmacy (as well as
a revised statement) will be put forward for adoption by
the Council at the congress in Bangkok.
A new working group of the Pharmacy Information Section
is looking into national strategic plans for the development and
use of medicines information.
In addition to work on the programmes for future conferences (Düsseldorf 2015 and Buenos Aires 2016), regular newsletters to members, and activities on discussion forums, work in progress at FIP includes the following.
SETTING STANDARDS FOR CHILDREN S MEDICINES
REFLECTING CHANGES IN HOSPITAL PRACTICE
ESTABLISHING CENTRES OF EXCELLENCE
KEEPING ETHICS UP TO DATE
PROVIDING TOOLS FOR BETTER MEDICINES INFORMATION
WORK IN PROGRESS
July 2013 saw the first convening of the FIP working group on
remuneration models for hospital and community pharmacies.
High- quality pharmaceutical care services are a must for
achieving responsible use of medicines, but a crucial cog is a
sustainable and supportive economic system that is properly
integrated in healthcare systems at national or provincial level
in order to fund these services.
ENABLING HIGH-QUALITY PHARMACEUTICAL SERVICES
read more
read more
read more